Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies
about
Guillain–Barré Syndrome (42 Cases) Occurring During a Zika Virus Outbreak in French PolynesiaElectrophysiological evaluation of chronic inflammatory demyelinating polyneuropathy and charcot-marie-tooth type 1: dispersion and correlation analysis.Treatment in inflammatory neuropathies.Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy.Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy.Axonal conduction block at intermediate nerve segments in pure motor Guillain-Barré syndrome.Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.An electrophysiological classification associated with Guillain-Barré syndrome outcomes.Rituximab Improves Subclinical Temporal Dispersion of Distal Compound Muscle Action Potential in Anti-MAG/SGPG Neuropathy Associated with Waldenström Macroglobulinemia: A Case Report.Comparison of 2-limb versus 3-limb electrodiagnostic studies in the evaluation of chronic inflammatory demyelinating polyneuropathy.Longitudinal changes of nerve conduction velocity, distal motor latency, compound motor action potential duration, and skin temperature during prolonged exposure to cold in a climate chamber.Compound motor action potential duration and latency are markers of recurrent laryngeal nerve injury.Increase of distal sensory action potential duration as a sensitive electrophysiological parameter in atypical case of acute inflammatory demyelinating polyneuropathy.European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the PeChronic inflammatory demyelinating polyneuropathy: Clinical subtypes and their correlation with electrophysiology
P2860
Q24261268-03A6FA2A-957D-414F-9E23-B34A6C59EFB2Q37287218-128326CB-675A-40C1-9F61-74AAE3C2F467Q37733512-7CD3C290-1598-4DD7-976B-DA482567442FQ37879052-C757D989-F905-4860-B18B-2A7984340EA3Q38171403-503572A7-9895-47AA-8BE2-D702AC9B7DD3Q38474826-55239327-FDA9-44D3-B438-7B7E1422F72BQ38590743-DBF6AC26-7F3F-4DA1-A50E-7A8DD1560B9EQ42203555-F48F03FE-F0E8-4032-B68E-B777FF95C828Q43221190-F4F630C6-CDAC-47E6-A44F-ED8F0A44AE0CQ45772974-4D2E2EE3-1B3A-4CC3-9115-002D8E90F6EDQ48564079-8BDE5506-701D-446B-B3C2-7FA7DCD1B5B4Q50879347-0012D359-6BA5-48B5-A060-52CFF3E9C633Q53276013-D8672D90-9BCB-4F35-928E-8AE23A20734FQ55052893-65894C8B-6194-45FE-93E8-0EB630F06459Q56771871-0D0BC232-F0B5-4685-AEA9-CA05F318B241
P2860
Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2009
@uk
name
Utility of the distal compound ...... of demyelinating neuropathies
@en
Utility of the distal compound ...... of demyelinating neuropathies
@nl
type
label
Utility of the distal compound ...... of demyelinating neuropathies
@en
Utility of the distal compound ...... of demyelinating neuropathies
@nl
prefLabel
Utility of the distal compound ...... of demyelinating neuropathies
@en
Utility of the distal compound ...... of demyelinating neuropathies
@nl
P2093
P1476
Utility of the distal compound ...... of demyelinating neuropathies
@en
P2093
Kazuaki Kanai
Kazumoto Shibuya
Koichi Hirata
Masahiro Mori
Norito Kokubun
Sagiri Isose
Saiko Nasu
Setsu Sawai
Sonoko Misawa
Yasunori Sato
P304
P356
10.1111/J.1529-8027.2009.00226.X
P577
2009-09-01T00:00:00Z